NPY mediates reward activity of morphine, via NPY Y1 receptors, in the nucleus accumbens shell

Behavioural Brain Research

Volumn 247, Issue , 2013, Pages 79-91

  Desai, Sagar J ^a   Upadhya, Manoj A ^a   Subhedar, Nishikant K ^b   Kokare, Dadasaheb M ^a  

^a RTM NAGPUR UNIVERSITY   (India)

^b INDIAN INSTITUTE OF SCIENCE EDUCATION AND RESEARCH   (India)

Author keywords

Brain stimulation reward; Immunohistochemistry; Neuropeptide Y; Nucleus accumbens shell; Operant conditioning chamber; Opioids

Indexed keywords

LEUCINE; MORPHINE; NALPHA (DIPHENYLACETYL) N (4 HYDROXYBENZYL) DEXTRO ARGININAMIDE; NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR; NEUROPEPTIDE Y RECEPTOR AGONIST; NEUROPEPTIDE Y1 RECEPTOR; NEUROPEPTIDE Y5 RECEPTOR; NEUROPEPTIDE YY1 RECEPTOR; PROLINE; UNCLASSIFIED DRUG;

ANATOMICAL VARIATION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARCUATE NUCLEUS; ARTICLE; BRAIN FUNCTION; CONTROLLED STUDY; DRUG PROTEIN BINDING; ELECTROENCEPHALOGRAM; IMMUNOREACTIVITY; MALE; MEDIAL FOREBRAIN BUNDLE; MESOLIMBIC DOPAMINERGIC SYSTEM; NERVE STIMULATION; NEUROMODULATION; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; REINFORCEMENT; REWARD; STRIA TERMINALIS;

ANIMALS; CONDITIONING, OPERANT; ELECTRIC STIMULATION; MALE; MORPHINE; NARCOTICS; NEUROPEPTIDE Y; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, NEUROPEPTIDE; REWARD; SELF ADMINISTRATION;

EID: 84876330236     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2013.03.018     Document Type: Article

References (56)

1. Belluzzi J.D., Stein L. Enkephalin may mediate euphoria and drive-reduction reward. Nature 1977, 266:556-558.
2. Goeders N.E., Lane J.D., Smith J.E. Self-administration of methionine enkephalin into the nucleus accumbens. Pharmacology Biochemistry and Behavior 1984, 20:451-455.
3. Jenck F., Gratton A., Wise R.A. Opioid receptor subtypes associated with ventral tegmental facilitation of lateral hypothalamic brain stimulation reward. Brain Research 1987, 423:34-38.
4. Goodman A. Neurobiology of addiction. An integrative review. Biochemical Pharmacology 2008, 75:266-322.
5. Phillips A.G., LePiane F.G. Reinforcing effects of morphine microinjection into the ventral tegmental area. Pharmacology Biochemistry and Behavior 1980, 12:965-968.
6. Welzl H., Kuhn G., Huston J.P. Self-administration of small amounts of morphine through glass micropipettes into the ventral tegmental area of the rat. Neuropharmacology 1989, 28:1017-1023.
7. Matthews R.T., German D.C. Electrophysiological evidence for excitation of rat ventral tegmental area dopamine neurons by morphine. Neuroscience 1984, 11:617-625.
8. Narita M., Suzuki T., Funada M., Misawa M., Nagase H. Blockade of the morphine-induced increase in turnover of dopamine on the mesolimbic dopaminergic system by kappa-opioid receptor activation in mice. Life Sciences 1993, 52:397-404.
9. Nelson A.J., Thur K.E., Horsley R.R., Spicer C., Marsden C.A., Cassaday H.J. Reduced dopamine function within the medial shell of the nucleus accumbens enhances latent inhibition. Pharmacology Biochemistry and Behavior 2011, 98:1-7.
10. Damaj MI, Zheng J, Martin BR, Kuhar MJ. Intrathecal CART (55-102) attenuates hyperlagesia and allodynia in a mouse model of neuropathic but not inflammatory pain. Peptides. 2006;27:2019-2023.
11. Kalange A.S., Kokare D.M., Singru P.S., Upadhya M.A., Chopde C.T., Subhedar N.K. Central administration of selective melanocortin 4 receptor antagonist HS014 prevents morphine tolerance and withdrawal hyperalgesia. Brain Research 2007, 1181:10-20.
12. Upadhya M.A., Dandekar M.P., Kokare D.M., Singru P.S., Subhedar N.K. Involvement of neuropeptide Y in the acute, chronic and withdrawal responses of morphine in nociception in neuropathic rats: behavioral and neuroanatomical correlates. Neuropeptides 2009, 43:303-314.
13. Stanley B.G., Kyrkouli S.E., Lampert S., Leibowitz S.F. Neuropeptide Y chronically injected into the hypothalamus: a powerful neurochemical inducer of hyperphagia and obesity. Peptides 1986, 7:1189-1192.
14. Quarta D., Leslie C.P., Carletti R., Valerio E., Caberlotto L. Central administration of NPY or an NPY-Y5 selective agonist increase in vivo extracellular monoamine levels in mesocorticolimbic projecting areas. Neuropharmacology 2011, 60:328-335.
15. Brown C.M., Coscina D.V., Fletcher P.J. The rewarding properties of neuropeptide Y in perifornical hypothalamus vs. nucleus accumbens. Peptides 2000, 21:1279-1287.
16. Schroeder J.P., Olive F., Koenig H., Hodge C.W. Intra-amygdala infusion of the NPY Y1 receptor antagonist BIBP 3226 attenuates operant ethanol self-administration. Alcoholism, Clinical and Experimental Research 2003, 27:1884-1891.
17. Kask A., Kivastik T., Rägo L., Harro J. Neuropeptide Y Y1 receptor antagonist BIBP3226 produces conditioned place aversion in rats. Progress in Neuro-Psychopharmacology and Biological Psychiatry 1999, 23:705-711.
18. Josselyn S.A., Beninger R.J. Neuropeptide Y: intraaccumbens injections produce a place preference that is blocked by cis-flupenthixol. Pharmacology Biochemistry and Behavior 1993, 46:543-552.
19. Sørensen G., Wegener G., Hasselstrøm J., Hansen T.V., Wörtwein G., Fink-Jensen A., Woldbye D.P. Neuropeptide Y infusion into the shell region of the rat nucleus accumbens increases extracellular levels of dopamine. Neuroreport 2009, 20:1023-1026.
20. Ault D.T., Radeff J.M., Werling L.L. Modulation of [3H]Dopamine release from rat nucleus accumbens by neuropeptide Y may involve a sigma1-like receptor. Journal of Pharmacology and Experimental Therapeutics 1998, 284:553-560.
21. Zhang Y., Lundeberg T., Yu L. Involvement of neuropeptide Y and Y1 receptor in antinociception in nucleus raphe magnus of rats. Regulatory Peptides 2000, 95:109-113.
22. Kotz C.M., Grace M.K., Briggs J., Levine A.S., Billington C.J. Effects of opioid antagonists naloxone and naltrexone on neuropeptide Y-induced feeding and brown fat thermogenesis in the rat. Neural site of action. Journal of Clinical Investigation 1995, 96:163-170.
23. Carlezon W.A., Chartoff E.H. Intracranial self-stimulation (ICSS) in rodents to study the neurobiology of motivation. Nature Protocols 2007, 2:2987-2995.
24. Esposito R., Kornetsky C. Morphine lowering of self-stimulation thresholds: lack of tolerance with long-term administration. Science 1977, 195:189-191.
25. Wise R.A. Addictive drugs and brain stimulation reward. Annual Review of Neuroscience 1996, 19:319-340.
26. Peciña S., Berridge K.C. Opioid site in nucleus accumbens shell mediates eating and hedonic 'liking' for food: map based on microinjection Fos plumes. Brain Research 2000, 863:71-86.
27. Trujillo K.A., Belluzzi J.D., Stein L. Naloxone suppression of self-stimulation is independent of response difficulty. Pharmacology Biochemistry and Behavior 1989, 33:147-155.
28. Robinson J.E., Fish E.W., Krouse M.C., Thorsell A., Heilig M., Malanga C.J. Potentiation of brain stimulation reward by morphine: effects of neurokinin-1 receptor antagonism. Psychopharmacology 2012, 220:215-224.
29. Koob G. Drug addiction. Neurobiology of Disease 2000, 7:543-545.
30. Ahmed S.H., Lutjens R., van der Stap L.D., Lekic D., Romano-Spica V., Morales M., et al. Gene expression evidence for remodeling of lateral hypothalamic circuitry in cocaine addiction. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:11533-11538.
31. Dandekar M.P., Singru P.S., Kokare D.M., Lechan R.M., Thim L., Clausen J.T., et al. Importance of cocaine- and amphetamine-regulated transcript peptide in the central nucleus of amygdala in anxiogenic responses induced by ethanol withdrawal. Neuropsychopharmacology 2008, 33:1127-1136.
32. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 1998, Academic Press, London.
33. Kokare D.M., Shelkar G.P., Borkar C.D., Nakhate K.T., Subhedar N.K. A simple and inexpensive method to fabricate a cannula system for intracranial injections in rats and mice. Journal of Pharmacological and Toxicological Methods 2011, 64:246-250.
34. Markou A., Koob G.F. Construct validity of a self-stimulation threshold paradigm: effects of reward and performance manipulations. Physiology and Behavior 1992, 51:111-119.
35. Tomasiewicz H.C., Todtenkopf M.S., Chartoff E.H., Cohen B.M., Carlezon W.A. The kappa-opioid agonist U69,593 blocks cocaine-induced enhancement of brain stimulation reward. Biological Psychiatry 2008, 64:982-988.
36. Miliaressis E., Rompré P.P., Durivage A. Psychophysical method for mapping behavioral substrates using a moveable electrode. Brain Research Bulletin 1982, 8:693-701.
37. Coulombe D., Miliaressis E. Fitting intracranial self-stimulation data with growth models. Behavioral Neuroscience 1987, 101:209-214.
38. Meena H., Nakhate K.T., Kokare D.M., Subhedar N.K. GABAA receptors in nucleus accumbens shell mediate the hyperphagia and weight gain following haloperidol treatment in rats. Life Sciences 2009, 84:156-163.
39. Taksande B.G., Kotagale N.R., Nakhate K.T., Mali P.D., Kokare D.M., Hirani K., et al. Agmatine in the hypothalamic paraventricular nucleus stimulates feeding in rats: involvement of neuropeptide Y. British Journal of Pharmacology 2011, 164:704-718.
40. Sagara H., Kitamura Y., Sendo T., Araki H., Gomita Y. Motivational effects of methamphetamine as measured by the runway method using priming stimulation of intracranial self-stimulation behavior. Biological and Pharmaceutical Bulletin 2008, 31:541-545.
41. Lin D., Koob G.F., Markou A. Differential effects of withdrawal from chronic amphetamine or fluoxetine administration on brain stimulation reward in the rat-interactions between the two drugs. Psychopharmacology 1999, 145:283-294.
42. Kornetsky C. Brain-stimulation reward: a model for the neuronal bases for drug-induced euphoria. NIDA Research Monograph 1985, 62:30-50.
43. Olds M.E. Reinforcing effects of morphine in the nucleus accumbens. Brain Research 1982, 237:429-440.
44. van der Kooy D., Mucha R.F., O'Shaughnessy M., Bucenieks P. Reinforcing effects of brain microinjections of morphine revealed by conditioned place preference. Brain Research 1982, 243:107-117.
45. Haberstock-Debic H., Wein M., Barrot M., Colago E.E., Rahman Z., Neve R.L., et al. Morphine acutely regulates opioid receptor trafficking selectively in dendrites of nucleus accumbens neurons. Journal of Neuroscience 2003, 23:4324-4332.
46. Mansvelder H.D. Yin and yang of VTA opioid signaling. Focus on both kappa and mu opioid agonists inhibit glutamatergic input to ventral tegmental area neurons. Journal of Neurophysiology 2005, 93:3046-3047.
47. De Vries T.J., Shippenberg T.S. Neural systems underlying opiate addiction. Journal of Neuroscience 2002, 22:3321-3325.
48. Koob G.F., Volkow N.D. Neurocircuitry of addiction. Neuropsychopharmacology 2010, 35:217-238.
49. Maric T., Tobin S., Quinn T., Shalev U. Food deprivation-like effects of neuropeptide Y on heroin self-administration and reinstatement of heroin seeking in rats. Behavioural Brain Research 2008, 194:39-43.
50. Herman Z.S. Neuropeptide Y and its mRNA in discrete brain areas after subchronic administration of neuroleptics. Acta Neurobiologiae Experimentalis 1996, 56:55-61.
51. Aoki C., Pickel V.M. Neuropeptide Y-containing neurons in the rat striatum: ultrastructure and cellular relations with tyrosine hydroxylase- containing terminals and with astrocytes. Brain Research 1988, 459:205-225.
52. Chronwall B.M., DiMaggio D.A., Massari V.J., Pickel V.M., Ruggiero D.A., O'Donohue T.L. The anatomy of neuropeptide-Y-containing neurons in rat brain. Neuroscience 1985, 15:1159-1181.
53. Heilig M. The NPY system in stress, anxiety and depression. Neuropeptides 2004, 38:213-224.
54. Woldbye D.P., Klemp K., Madsen T.M. Neuropeptide Y attenuates naloxone-precipitated morphine withdrawal via Y5-like receptors. Journal of Pharmacology and Experimental Therapeutics 1998, 284:633-636.
55. Migita K., Loewy A.D., Ramabhadran T.V., Krause J.E., Waters S.M. Immunohistochemical localization of the neuropeptide Y Y1 receptor in rat central nervous system. Brain Research 2001, 889:23-37.
56. Saurer T.B., Ijames S.G., Lysle D.T. Neuropeptide Y Y1 receptors mediate morphine-induced reductions of natural killer cell activity. Journal of Neuroimmunology 2006, 177:18-26.